Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 359 (LINC00359) is a human long intergenic non-coding RNA (lincRNA) gene that produces a transcript longer than 200 nucleotides and does not encode a protein[1][3][5]. LINC00359, like other lincRNAs, is likely involved in gene regulatory roles including chromatin remodeling, RNA stabilization, and the fine-tuning of neighboring or distant gene expression, often in a tissue-specific manner[3][5]. The precise function of LINC00359 has not been experimentally determined, and it is not currently considered a direct therapeutic target, receptor, enzyme, or transporter[1][3]. LINC00359 belongs to a class of RNAs with diverse mechanisms and evolving biological roles, many of which remain to be discovered or functionally validated[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 359 (LINC00359).